Caisse de depot et placement du Quebec Takes Position in Cabot Corporation $CBT

Key Points

• Caisse de depot et placement du Quebec acquired 95,889 Cabot shares worth approximately $8.7 million, giving it a 0.19% stake. Institutional investors collectively own 93.18% of the company.
• Cabot exceeded quarterly earnings and revenue expectations, reporting $1.67 in EPS on $982 million in revenue, while revenue increased 6.4% year over year. The company issued fiscal 2026 EPS guidance of $6.15–$6.45.
• Cabot maintains a quarterly dividend of $0.4725 per share, or $1.89 annualized, yielding about 2.3%. Analysts have a consensus “Hold” rating and an average price target of $89, compared with the stock’s opening price of $83.67.

Caisse de depot et placement du Quebec acquired a new position in Cabot Corporation (NYSE:CBT - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 95,889 shares of the specialty chemicals company's stock, valued at approximately $8,709,000. Caisse de depot et placement du Quebec owned approximately 0.19% of Cabot as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Man Group plc bought a new position in Cabot during the 2nd quarter valued at about $4,310,000. Jupiter Topco LLC bought a new stake in shares of Cabot in the second quarter worth approximately $2,116,000. Hsbc Holdings PLC purchased a new position in shares of Cabot during the second quarter valued at approximately $1,690,000. Canada Pension Plan Investment Board purchased a new position in shares of Cabot during the second quarter valued at approximately $836,000. Finally, Legal & General Group Plc bought a new position in Cabot during the second quarter valued at approximately $6,900,000. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Stock Performance

CBT opened at $83.67 on Friday. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The company has a market cap of $4.32 billion, a price-to-earnings ratio of 23.57, a PEG ratio of 10.98 and a beta of 0.84. The company's 50 day moving average is $87.62 and its 200 day moving average is $81.19. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $94.53.

Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating analysts' consensus estimates of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business had revenue of $982.00 million during the quarter, compared to analysts' expectations of $943.16 million. During the same period in the prior year, the company earned $1.90 earnings per share. The firm's revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities research analysts predict that Cabot Corporation will post 6.35 EPS for the current year.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot's dividend payout ratio is 53.24%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on CBT shares. UBS Group cut their target price on shares of Cabot from $97.00 to $92.00 and set a "neutral" rating for the company in a research report on Wednesday, August 5th. JPMorgan Chase & Co. increased their price target on Cabot from $70.00 to $78.00 and gave the company an "underweight" rating in a report on Friday, August 7th. Wall Street Zen raised Cabot from a "hold" rating to a "buy" rating in a report on Sunday, August 9th. Weiss Ratings restated a "hold (c)" rating on shares of Cabot in a research note on Friday, August 21st. Finally, Truist Financial set a $100.00 price objective on Cabot in a report on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Cabot currently has a consensus rating of "Hold" and an average price target of $89.00.

Insider Activity at Cabot

In related news, CEO Sean D. Keohane sold 2,779 shares of the firm's stock in a transaction on Monday, August 24th. The stock was sold at an average price of $85.50, for a total value of $237,604.50. Following the transaction, the chief executive officer directly owned 288,873 shares of the company's stock, valued at approximately $24,698,641.50. This trade represents a 0.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.08% of the stock is owned by company insiders.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source